InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（1 笔）
内部人交易记录
其他已披露买入
0
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the complete record of transactions filed by Gardner Jason, Autre. Officer active across 1 company, notably Magenta Therapeutics, Inc.. Aggregated, 4 disclosures have been recorded. Split: 0 buy · 1 sell. Total volume traded: €82k. History available since 14 September 2021. The latest transaction was filed on 30 November 2022 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Gardner Jason
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报4 总计
3,000 股@ US$0.941.6% 占其流量Common StockSEC:0000899243-22-037431:0
3,000 股@ US$0.993.2% 占其流量Common StockSEC:0000899243-22-021184:0
14,340 股@ US$6.7393.7% 占其流量Common StockSEC:0000899243-21-036599:0
50,000 股0Common StockSEC:0000899243-21-036335:0
4 条申报中的 4 条
About Gardner Jason
Jason Gardner is a senior executive at Magenta Therapeutics, Inc. He holds a leadership position in international optimization and strategic initiatives. His role is essential in guiding the company in its innovation and transformation efforts.
